← Leaderboards
Mark C Wolff
Emmes Corporation
$1,988,020
Attributed
$1,988,020
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $486.3K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$1,988,020 · 2
By mechanism
R01$1,453,490 · 1
N01$534,530 · 1
Top collaborators
No co-investigators on record.
Most similar at Emmes Corporation
Same institution · by research overlap
- Shelly L Carter$4,502,619
- Anne S Lindblad$7,032,627
- Donald M Stablein$11,969,864
Others in their field
Top investigators on “Embryo /Fetus Drug Adverse Effect”
- Elizabeth A Thom · George Washington University$17,168,316
- Kimford J Meador · Medical College Of Georgia (Mcg)$8,208,933
- Allen A Mitchell · Boston University Medical Campus$5,567,279
- Hendree E. Jones · Johns Hopkins University$3,936,808
- Katherine L. Wisner · Case Western Reserve University$3,614,407
- Kenneth C Rich · University Of Illinois At Chicago$3,580,497
Research focus
Embryo /Fetus Drug Adverse EffectCommunicable DiseasesBehavioral /Social Science Research TagData CollectionBiomedical ResourceComorbidityDevelopmental NeurobiologyEpilepsyFemaleHuman SubjectHuman Therapy EvaluationIntelligence TestsLongitudinal Human StudyNeuropsychologyOutcomes ResearchParentsPatient Oriented ResearchPhenytoinQuestionnairesSocioeconomicsAnticonvulsantsValproateCarbamazepineChild Behavior Disorders
Grant awards (5)
Neurodevelopment Effects of Antiepileptic Drugs$486,307
R01 · FY2006 · NS · contact PI
Neurodevelopment Effects of Antiepileptic Drugs$483,509
R01 · FY2005 · NS
Neurodevelopment Effects of Antiepileptic Drugs$483,674
R01 · FY2004 · NS
DATA COORDINATING CNTR. FOR CLINICAL &EPIDEMIOLOGIC STU$534,530
N01 · FY2000 · AI
DATA COORDINATING CNTR. FOR CLINICAL &EPIDEMIOLOGIC STU$0
N01 · FY2000 · AI